Topics

MorphoSys AG, Company Profile

02:13 EST 26th February 2020 | BioPortfolio

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.The Company, founded in 1992, possesses the unique HuCAL technology (the Human Combinatorial Antibody Library). This library comprises more than ten billion different, fully human antibodies. HuCAL is a very powerful technology, which allows rapid and automated production of high-affinity antibodies. The most important feature of the library is its capability of optimizing fully human antibodies to meet predefined specifications.

Location

Lena-Christ-Strasse 48
Martinsried
Planegg
82152
Germany

Contact

Phone: 49 (0)89 / 899 27-0
Fax: 49 (0)89 / 899 27-222
Email: investors@morphosys.com


News Articles [519 Associated News Articles listed on BioPortfolio]

Incyte and MorphoSys Ink $1.1 Billion Immuno-Oncology Pact

MorphoSys AG and Incyte Corporation have inked a collaboration and license deal to further develop and commercialize MorphoSys’ anti-CD19 antibody tafasitamab around the world.

MorphoSys weiter im Rallyemodus!

Am 28. Oktober hatten wir getitelt: "MorphoSys: War das nur ein Ausrutscher?" Im Text stand unter anderem: "Bei MorphoSys stehen 2020 zahlreichen Ergebnisse aus klinischen Studien der Phase III an ...

Morphosys-Aktie dank Millionen von Incyte auf Kurs zu Rekordhoch

Für Kurseuphorie hat am Montag im vorbörslichen Handel auf Tradegate die Nachricht über eine Kooperation von MorphoSys mit dem US-Pharmaunternehmen Incyte gesorgt. Im Rahmen dieser erhält Morphosy...

Morphosys: Hohes Übernahmepotenzial?

Der Titel des Biotech-Unternehmens Morphosys kämpft derzeit wieder mit der Kursmarke von 100 Euro und in den vergangenen zwei Wochen können sich Morphosys-Aktionäre über einen Kursgewinn in Höhe ...

Morphosys: Auf einmal ist alles anders

Die Aktie des Biotech-Unternehmens Morphosys kämpft derzeit wieder mit der Kursmarke von 100 Euro. In den vergangenen zwei Wochen können sich Morphosys-Aktionäre über einen Kursgewinn in Höhe von...

wikifolio whispers p.m. zu MorphoSys, Wirecard, Bechtle ...

MorphoSys -0.04% RaketenTrading (GOFISH): Der Trade lief ebenfalls nicht. Verlust wird begrenzt. Wir warten auf chancen (16.01. 13:39) >> mehr comments zu MorphoSys: www.boerse-social.com/launch/ak...

MorphoSys, Incyte Agree To Co-commercialize Tafasitamab In The U.S.

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) and Incyte Corp. (INCY) have agreed on a collaboration and license agreement to further develop and commercialize MorphoSys' anti-CD19 antibody...

MorphoSys: War das nur ein Ausrutscher?

Erst am Sonntag hatten wir im Express-Service unter der Überschrift: "MorphoSys: "Dausend" Euro werden es wohl nicht, aber…" über eine kommende Trading-Chance mit MorphoSys ISIN: DE0006632003 beri...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

MorphoSys GmbH

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

MorphoSys AG,

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

Antibodies by Design

Antibodies by Design uses proven MorphoSys recombinant antibody technology to provide high quality monoclonal antibodies to its customers in record time. The HuCAL GOLD® library contains over 15 bill...

More Information about "MorphoSys AG," on BioPortfolio

We have published hundreds of MorphoSys AG, news stories on BioPortfolio along with dozens of MorphoSys AG, Clinical Trials and PubMed Articles about MorphoSys AG, for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MorphoSys AG, Companies in our database. You can also find out about relevant MorphoSys AG, Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record